KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells

Acute myeloid leukemia (AML) is a clonal hematologic malignant disease of developing myeloid cells that have acquired aberrant survival, uncontrolled proliferation and a block in normal hematopoietic cell differentiation. Standard chemotherapy often induces remissions in AML patients, but the diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Y, Kauffman, M, Shacham, S, Wang, J C Y, Look, A T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220128/
https://www.ncbi.nlm.nih.gov/pubmed/27211268
http://dx.doi.org/10.1038/leu.2016.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220128/
https://www.ncbi.nlm.nih.gov/pubmed/27211268
http://dx.doi.org/10.1038/leu.2016.145

Ejemplares similares